Free Trial

Traws Pharma (TRAW) Earnings Date, Estimates & Call Transcripts

Traws Pharma logo
$1.60 +0.03 (+1.58%)
As of 12:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Traws Pharma Earnings Summary

Traws Pharma released Q1 2025 earnings on May 15, 2025, reporting an EPS of $2.09, which beat analysts' consensus estimates of -$8.04 by $10.13. Quarterly revenue was reported to be $0.06 million, below analyst estimates of $0.06 million. Traws Pharma currently has a trailing EPS of -$32.81

Upcoming Q2
Earnings Date
Aug. 21Before Market OpensEstimated
Consensus EPS
(May. 15)
-$8.04
Actual EPS
(May. 15)
$2.09 Beat By $10.13
Actual Revenue
(May. 15)
$0.06M

Q1 2025 Earnings Resources

TRAW Upcoming Earnings

Traws Pharma's next earnings date is estimated for Thursday, August 21, 2025, based on past reporting schedules.

Get Traws Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Traws Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TRAW Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TRAW Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Traws Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.31-$0.31-$0.31
Q2 20251-$0.33-$0.33-$0.33
Q3 20251-$0.35-$0.35-$0.35
Q4 20251-$0.36-$0.36-$0.36

Traws Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/21/2025
(Estimated)
--------
5/15/2025Q1 2025-$8.04$2.09+$10.13$2.09$0.06M$0.06M
3/31/2025Q4 2024 & Study Update-$7.00$95.66+$102.66$95.66$0.06M$0.06M
8/15/2024Q2 2024--$4.87--$4.87-$0.06M
5/15/2024Q1 2024-$0.24-$0.24--$0.24$0.06M$0.06M
4/1/2024Q4 2023--$0.20--$0.20-$0.06M
11/14/2023Q3 2023-$0.26-$0.23+$0.03-$0.23$0.06M$0.06M
8/10/2023Q2 2023-$0.29-$0.20+$0.09-$0.20$0.06M$0.06M

Traws Pharma Earnings - Frequently Asked Questions

Traws Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 21st, 2025 based off last year's report dates. Learn more on TRAW's earnings history.

In the previous quarter, Traws Pharma (NASDAQ:TRAW) reported $2.09 earnings per share (EPS) to beat the analysts' consensus estimate of ($8.04) by $10.13. Learn more on analysts' earnings estimate vs. TRAW's actual earnings.

Traws Pharma (NASDAQ:TRAW) has a recorded annual revenue of $230,000.00.

Traws Pharma (NASDAQ:TRAW) has a recorded net income of -$166.52 million. TRAW has generated -$32.81 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat



This page (NASDAQ:TRAW) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners